Gene therapeutic approaches to induction and maintenance of tolerance
- PMID: 11890616
- DOI: 10.3109/08830180109045582
Gene therapeutic approaches to induction and maintenance of tolerance
Abstract
Tolerance induction would be an ideal way to treat autoimmune diseases, especially if achievable in primed individuals. Moreover, specific tolerance would preclude the need for immunosuppressive treatment with its side effects. In this review, we will revisit the historical concepts of tolerance, and introduce a novel approach to tolerance via gene therapy. Our model system is based on the tolerogenicity of IgG carriers and B-cell antigen presentation. Results with this model demonstrate that it is simple and effective even in primed recipients, and has proven efficacy in three autoimmune models. We discuss the mechanisms of tolerance with fusion IgG's and analyze how our model of gene therapy approached can be utilized to fit in the future treatment of autoimmune conditions.
Similar articles
-
Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.Arch Immunol Ther Exp (Warsz). 2001;49(6):407-15. Arch Immunol Ther Exp (Warsz). 2001. PMID: 11814234 Review.
-
Gene therapy for immunological tolerance: using 'transgenic' B cells to treat inhibitor formation.Haemophilia. 2010 May;16(102):89-94. doi: 10.1111/j.1365-2516.2010.02203.x. Haemophilia. 2010. PMID: 20536991
-
Tolerance induction via a B-cell delivered gene therapy-based protocol: optimization and role of the Ig scaffold.Cell Immunol. 2005 May;235(1):12-20. doi: 10.1016/j.cellimm.2005.06.007. Epub 2005 Aug 10. Cell Immunol. 2005. PMID: 16098495
-
Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?Gene Ther. 2004 Oct;11(20):1487-96. doi: 10.1038/sj.gt.3302327. Gene Ther. 2004. PMID: 15343360
-
Treating autoimmune diseases through restoration of antigen-specific immune tolerance.Arch Immunol Ther Exp (Warsz). 2006 Jan-Feb;54(1):1-13. doi: 10.1007/s00005-006-0001-7. Epub 2006 Jan 23. Arch Immunol Ther Exp (Warsz). 2006. PMID: 16642252 Review.
Cited by
-
B cells induce tolerance by presenting endogenous peptide-IgG on MHC class II molecules via an IFN-gamma-inducible lysosomal thiol reductase-dependent pathway.J Immunol. 2008 Jul 15;181(2):1153-60. doi: 10.4049/jimmunol.181.2.1153. J Immunol. 2008. PMID: 18606668 Free PMC article.
-
Factor VIII: Perspectives on Immunogenicity and Tolerogenic Strategies.Front Immunol. 2020 Jan 17;10:3078. doi: 10.3389/fimmu.2019.03078. eCollection 2019. Front Immunol. 2020. PMID: 32010137 Free PMC article. Review.
-
PiggyBac-mediated cancer immunotherapy using EBV-specific cytotoxic T-cells expressing HER2-specific chimeric antigen receptor.Mol Ther. 2011 Dec;19(12):2133-43. doi: 10.1038/mt.2011.131. Epub 2011 Jul 19. Mol Ther. 2011. PMID: 21772253 Free PMC article.
-
The secretory IFN-gamma response of single CD4 memory cells after activation on different antigen presenting cell types.Clin Immunol. 2007 Sep;124(3):267-76. doi: 10.1016/j.clim.2007.05.012. Epub 2007 Jul 13. Clin Immunol. 2007. PMID: 17632036 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical